Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Plos One|March 12, 2026
Time restricted EAting for Type 2 diabetes and MEtabolic health: The TEA TIME trial study protocolMatthew Retnakaran, Vittória L Lessa, Caroline K Kramer
Circulation. Cardiovascular Quality and Outcomes|October 9, 2019
Dog Ownership and Survival: A Systematic Review and Meta-AnalysisCaroline K Kramer, Sadia Mehmood, Renée S Suen
Clinical Endocrinology|February 13, 2010
Does leptin predict incident hypertension in older adults?Caroline K Kramer, Denise von Mühlen, Elizabeth Barrett-Connor
The Journal of Clinical Endocrinology and Metabolism|June 17, 2015
Effect of Short-term Intensive Insulin Therapy on Post-challenge Hyperglucagonemia in Early Type 2 DiabetesCaroline K Kramer, Bernard Zinman, Haysook Choi, et al.
BMJ Open Diabetes Research & Care|August 23, 2016
Predictors of sustained drug-free diabetes remission over 48 weeks following short-term intensive insulin therapy in early type 2 diabetesCaroline K Kramer, Bernard Zinman, Haysook Choi, et al.
Diabetes Care|February 20, 2014
Glycemic variability in patients with early type 2 diabetes: the impact of improvement in β-cell functionCaroline K Kramer, Haysook Choi, Bernard Zinman, et al.
Lancet (London, England)|December 12, 2022
The impact of urbanisation on the cardiometabolic health of Indigenous Brazilian peoples: a systematic review and meta-analysis, and data from the Brazilian Health registryCaroline K Kramer, Cristiane B Leitão, Luciana V Viana
Lancet (London, England)|September 16, 2014
Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysisConrad Eng, Caroline K Kramer, Bernard Zinman, et al.
Diabetologia|August 9, 2015
Sex of the baby and risk of gestational diabetes mellitus in the mother: a systematic review and meta-analysisDiana Jaskolka, Ravi Retnakaran, Bernard Zinman, et al.
Diabetes, Obesity & Metabolism|January 25, 2018
Efficacy of glucagon-like peptide-1 receptor agonists compared to dipeptidyl peptidase-4 inhibitors for the management of type 2 diabetes: A meta-analysis of randomized clinical trialsSusan Tran, Ravi Retnakaran, Bernard Zinman, et al.
Pageof 9